Enzymology in Drug Discovery

Enzymes are the proteins in the drug design that act as drug targets for the diseases in the process of drug discovery and development. There are number of drug targets involved in the designing of the drug.

Drug target as a nucleic acid or a protein (e.g. an enzyme, a receptor) whose activity can be modified by a drug. The drug can be a small-molecular-weight chemical compound or a biological, such as an antibody or a recombinant protein. The drug target should have been shown to be effective/mechanistically involved in the disease by relevant in vitro or in vivo models.

  • Drug designing using enzymes
  • Drug development using enzymes
  • Drug modelling
  • Drug targeting

Related Conference of Enzymology in Drug Discovery

July 23-24, 2026

22nd World Congress on Structural Biology

Aix-en-Provence, France
September 03-04, 2026

16th World Glycobiology Congress

Paris, France
September 21-22, 2026

24th International Conference on Structural Biology

Barcelona, Spain

Enzymology in Drug Discovery Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in